Clinical Trial Update: Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy Adults [Phase 2]

View source ↗

Summary

A Phase 2 efficacy study evaluating intramuscular CssBA+dmLT against moderate-to-severe diarrhea in healthy adults infected with enterotoxigenic Escherichia col…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterotoxigenic Escherichia Coli Infection

Drugs mentioned

• CssBA+dmLT

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Escherichia Infection | Phase 2 | Status: COMPLETED